PHASE II STUDY OF METRONOMIC ORAL VINORELBINE IN ADVANCED BREASTCANCER - ND
- Conditions
- Advanced breast cancerMedDRA version: 9.1Level: LLTClassification code 10057654Term: Breast cancer female
- Registration Number
- EUCTR2007-002588-28-IT
- Lead Sponsor
- ISTITUTO EUROPEO DI ONCOLOGIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Histologically or cytologically proven diagnosis breast cancer with evidence of 1) unresectable, locally recurrent, or 2) metastatic disease. At least one bidimensionally measurable lesion adequately measured by imaging procedure (See section 15). Prior chemotherapy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Patient with T4d disease inflammatory cancer as unique disease, symptomatic lung lymphangitis.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method